ALL vs BCAB · P/E 4.9, $56.89B cap vs $5.9M cap
The Allstate Corporation (ALL) versus Bioatla Inc (BCAB) — a side-by-side from cached financials, not a winner call.
The Allstate Corporation (ALL) is a insurance - property & casualty company listed on US.
Bioatla Inc (BCAB) is a biotechnology company listed on NASDAQ.
ALL does not have a complete income-statement cache yet.
Latest reported BCAB revenue for 2023-09-30 was $0. Net income was -$33.3M. BCAB currently screens at market cap $5.9M.
ALL currently screens at market cap $56.89B and trailing P/E 4.9. BCAB currently screens at market cap $5.9M.
Not investment advice. Open the ALL and BCAB stock pages for the full models.
Not investment advice.